Which Medications Treat Non-Small Cell Lung Cancer?
Several types of medication may be used to treat non-small cell lung cancer (NSCLC). What’s recommended for you depends on the stage of cancer and other factors.
Lumakras
Used for Lung Cancer
Used for Lung Cancer
Lumakras (sotorasib) is a medication that’s used for metastatic non-small cell lung cancer (NSCLC). In particular, it’s used for adults who have a specific mutation called KRAS G12C in their lung cancer. Lumakras (sotorasib) is typically recommended only when first-choice treatment doesn’t work anymore. It can be a convenient option since it’s taken by mouth once a day. But, it commonly causes bothersome side effects, like stomach upset and fatigue.
What is Lumakras (sotorasib)?
What is Lumakras (sotorasib) used for?
- Metastatic non-small cell lung cancer (NSCLC) with a KRAS G12C mutation, after having tried at least one previous cancer treatment
How Lumakras (sotorasib) works
Lumakras (sotorasib) is a KRAS G12C inhibitor. KRAS is a protein in your body that sends signals to your cells to grow and divide. In certain lung cancers, a mutation (change) in KRAS called G12C leads to uncontrolled cell growth. Lumakras (sotorasib) attaches to KRAS proteins with the G12C mutation. By doing so, the medication helps block tumor growth.
Drug facts
| Common Brands | Lumakras |
|---|---|
| Drug Class | KRAS G12C inhibitor |
| Controlled Substance Classification | Not a controlled medication |
| Generic Status | No lower-cost generic available |
| Availability | Prescription only |
Side effects of Lumakras (sotorasib)
The following side effects may get better over time as your body gets used to the medication. Let your healthcare provider know immediately if you continue to experience these symptoms or if they worsen over time.
Common Side Effects
- Diarrhea (42%)
- Muscle or bone pain (35%)
- Fatigue (26%)
- Nausea (26%)
- Cough (20%)
Less Common Side Effects
- Vomiting
- Constipation
- Stomach pain
- Shortness of breath
- Swelling
Lumakras (sotorasib) serious side effects
Contact your healthcare provider immediately if you experience any of the following.
- Liver injury: pain in the right side of the stomach, yellowing of the eyes or skin, dark or brown urine
- Lung damage: cough, shortness of breath, fever
The following Lumakras (sotorasib) side effects have also been reported
Side effects that you should report to your care team as soon as possible:
- Allergic reactions—skin rash, itching, hives, swelling of the face, lips, tongue, or throat
- Dry cough, shortness of breath or trouble breathing
- Liver injury—right upper belly pain, loss of appetite, nausea, light-colored stool, dark yellow or brown urine, yellowing skin or eyes, unusual weakness or fatigue
Side effects that usually do not require medical attention (report these to your care team if they continue or are bothersome):
- Diarrhea
- Fatigue
- Muscle pain
- Nausea
- Vomiting
Get your GoodRx coupon
N/A
GoodRx discount
$23028.75
Pros and cons of Lumakras (sotorasib)
Pros
- Oral medication that’s taken once a day
- Targeted therapy option for people with metastatic non-small cell lung cancer with a KRAS G12C mutation
Cons
- Commonly causes diarrhea, nausea, muscle pain, and fatigue
- Only recommended after first-choice treatment hasn’t worked
Pharmacist tips for Lumakras (sotorasib)
- The full dose of Lumakras (sotorasib) is 960 mg once a day. In order to make the 960 mg dose, you’ll need three 320 mg tablets or eight 120 mg tablets. Take the entire dose at once each day. You don’t need to spread out the tablets throughout the day.
- Swallow Lumakras (sotorasib) tablets whole. Don’t cut or crush the tablets.
- If you’re having trouble swallowing Lumakras (sotorasib) tablets, you can place your dose in a glass with 4 ounces (120 mL) of room-temperature tap water. Stir or swirl the cup for about 3 minutes until the tablets break up into small pieces (the tablets won’t dissolve completely). Drink the mixture right away, and don’t chew any solid tablet pieces. Add another 4 ounces (120 mL) of water to the glass, swirl the mixture, and drink. This makes sure you’ve taken all of the medication for your dose.
- If you need to take medication for heartburn, avoid medications like omeprazole (Prilosec) and famotidine (Pepcid AC) while you’re taking Lumakras (sotorasib). These medications might make Lumakras (sotorasib) not work as well. Instead, you can use an antacid like Tums. Just make sure to take Lumakras (sotorasib) 4 hours before or 10 hours after the antacid so the medications don’t interfere with each other.
- If you’re starting any new medications, supplements, or herbal products, talk with your provider or pharmacist first to make sure they’re safe to take with Lumakras (sotorasib). Lumakras (sotorasib) can interact with other medications and supplements. Depending on what the specific interaction is, this can affect your risk of side effects or how well your medications work. For example, taking rosuvastatin (Crestor) with Lumakras (sotorasib) can possibly raise your risk of side effects from the cholesterol medication like joint pain or headache.
- Talk with your provider or pharmacist about handling Lumakras (sotorasib) safely. Store the medication away from children and pets.
Risks and warnings for Lumakras (sotorasib)
Lumakras (sotorasib) can cause some serious health issues. This risk may be even higher for certain groups. If this worries you, talk to your doctor or pharmacist about other options.
Liver injury
Lumakras (sotorasib) might cause damage to your liver. Because of this risk, you’ll need to get blood tests done so your healthcare provider can track how well your liver is working. You’ll typically need these blood tests before you start Lumakras (sotorasib), every 3 weeks when you first start, and then less often after that. In studies, some people experienced liver injury within the first 2 months of starting Lumakras (sotorasib). Let your healthcare team know if you notice signs of liver damage, such as pain in the right side of the stomach, yellowing of the eyes or skin, or dark or brown urine. If your provider suspects that you have liver damage, your provider might have you take a break from Lumakras (sotorasib). Once your liver test results return to normal, you might be able to restart the medication at a lower dose.
Lung damage
Although rare, Lumakras (sotorasib) can cause damage to the lungs, which can sometimes be life-threatening. In studies, lung problems started within the first 4 months of taking Lumakras (sotorasib). Let your healthcare team know if you experience new or worsened cough, shortness of breath, or fevers. You’ll probably need to stop the medication while your provider checks your lungs for problems.
Lumakras (sotorasib) dosage
The average cost for 120 tablets of 240mg of of Lumakras (sotorasib) is $23,028.75 with a free GoodRx coupon.
Tablet
Tablet| Dosage | Quantity | Price as low as | Price per unit |
|---|---|---|---|
| 240mg of | 120 tablets | $23,028.75 | $191.91 |
Typical dosage for Lumakras (sotorasib)
The typical dose is 960 mg by mouth once a day, with or without food.
Lumakras (sotorasib) is available as 120 mg and 320 mg tablets. The daily dose is taken as eight 120 mg tablets or three 320 mg tablets at one time each day.
How much does Lumakras (sotorasib) cost?
To access savings, use a GoodRx coupon and pay just a fraction of the retail price.
Lumakras (brand)
$23,028.75
What are alternatives to Lumakras (sotorasib)?
There are a number of medications that your doctor can prescribe in place of Lumakras (sotorasib). Compare a few possible alternatives below.
News about Lumakras (sotorasib)
What Novel Drugs Did the FDA Approve in 2021?
In 2021, the FDA approved 50 novel drugs. This includes medications being approved for new treatments and novel drugs for rare diseases. Learn more about the novel drugs approved in 2021 and what’s in store for 2022.
FDA Breakthrough Therapy Designation: How Does It Affect Medication Development?
The FDA has different ways of making medication development as efficient as possible. One method is called the breakthrough therapy designation. This designation helps streamline the development and review of medications for serious medical conditions. Learn more about the breakthrough therapy designation with GoodRx.
Lumakras (sotorasib) images
